𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new indication for liver transplantation: Nodular regenerative hyperplasia in human immunodeficiency virus–infected patients

✍ Scribed by Mariagrazia Tateo; Mylène Sebagh; Marie-Pierre Bralet; Elina Teicher; Daniel Azoulay; Vincent Mallet; Stanislas Pol; Denis Castaing; Didier Samuel; Jean-Charles Duclos-Vallée

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
219 KB
Volume
14
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis

Nodular regenerative hyperplasia is one of the causes of noncirrhotic portal hypertension and has recently been described in human immunodeficiency virus-infected patients, and the potential role of a prothrombotic state and hepatotoxic antiretroviral medication has been suggested. Moreover, it is now established that liver transplantation is feasible in HIV-infected patients. We describe here our experience concerning 3 HIV-infected patients with severe complications of nodular regenerative hyperplasia treated with liver transplantation.

📜 SIMILAR VOLUMES

Liver transplantation in human immunodef
Liver transplantation in human immunodeficiency virus–infected patients: Procoagulant, but is antithrombotic prophylaxis required?
✍ P. Thomas Cherian; Wesal Alrabih; Abdel Douiri; Alberto Quaglia; Michael A. Hene 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Liver transplantation (LT) for human immunodeficiency virus (HIV)-positive recipients with end-stage liver disease has become an accepted practice. However, because these patients are increasingly being recognized as prothrombotic, we reviewed their posttransplant thrombotic complications. Because m

Enfuvirtide: A safe and effective antire
Enfuvirtide: A safe and effective antiretroviral agent for human immunodeficiency virus–infected patients shortly after liver transplantation
✍ Elina Teicher; Chadi Abbara; Jean-Charles Duclos-Vallée; Teresa Antonini; Lauren 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

The aim of this study was to evaluate the impact of an enfuvirtide-based antiretroviral (ARV) regimen on the management of immunosuppression and follow-up in hepatitis C virus (HCV)/hepatitis B virus (HBV)/human immunodeficiency virus (HIV)-coinfected liver transplant patients in comparison with a l

The model for end-stage liver disease sc
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end-stage liver disease: A prospective cohort study
✍ Javier Murillas; Antonio Rimola; Montserrat Laguno; Elisa de Lazzari; Javier Ras 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

End-stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with par